糖尿病和心血管结局试验:临床实践中使用胰高血糖素样肽-1受体激动剂的综述

{"title":"糖尿病和心血管结局试验:临床实践中使用胰高血糖素样肽-1受体激动剂的综述","authors":"R. Daya, N. G. Mahyoodeen, Z. Bayat","doi":"10.36303/sagp.2021.2.3.0073","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":21867,"journal":{"name":"South African General Practitioner","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diabetes and cardiovascular outcome trials: a review with a focus on the use of glucagon-like peptide-1 receptor agonists in clinical practice\",\"authors\":\"R. Daya, N. G. Mahyoodeen, Z. Bayat\",\"doi\":\"10.36303/sagp.2021.2.3.0073\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":21867,\"journal\":{\"name\":\"South African General Practitioner\",\"volume\":\"3 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"South African General Practitioner\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36303/sagp.2021.2.3.0073\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"South African General Practitioner","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36303/sagp.2021.2.3.0073","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}